FPGEE for National Association of Boards of Pharmacy (NABP) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the FPGEE Exam. Study key pharmacy topics with quizzes and flashcards. Every question includes hints and explanations. Ace your exam!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


What is the primary function of third-generation progestins compared to earlier generations?

  1. Fewer androgenic properties

  2. Higher androgenic properties

  3. Increased estrogenic activity

  4. Lower affinity for progesterone receptors

The correct answer is: Fewer androgenic properties

The primary function of third-generation progestins compared to earlier generations is characterized by having fewer androgenic properties. This distinction is significant because it enhances the therapeutic profile of these medications, making them a preferred choice in contraceptive formulations and hormone replacement therapy for individuals who may experience adverse effects due to androgenic activity. Third-generation progestins, such as desogestrel and norgestimate, are designed to minimize side effects like weight gain, acne, and hirsutism, which can occur with progestins that exhibit higher androgenic activity. This reduction in androgenic effects not only improves patient satisfaction but also broadens the range of individuals who can use hormonal contraceptives without the risk of undesirable androgenic side effects. Evaluating the other options provides further insight into the distinctiveness of third-generation progestins. Higher androgenic properties would be contrary to the advancements made in this generation, and increased estrogenic activity does not accurately describe any progestin's primary functional role, as progestins are not associated with estrogenic effects but rather with progesterone-like effects. Finally, lower affinity for progesterone receptors would undermine the effectiveness of these medications; third-generation progestins maintain a strong affinity for progesterone receptors, which is